Pharmaceuticals

The Rise Of Chugai Pharmaceutical Introduces Bispecific Antibody Breakthrough In Follicular Lymphoma Treatment Is Influencing The Quadrivalent Market

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Quadrivalent Market Progress Between 2026 And 2030?

The quadrivalent market has witnessed substantial growth in recent years. Its value is expected to rise from $9.51 billion in 2025 to $10.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.8%. This historical expansion can be linked to the increasing occurrence of influenza, governmental vaccination programs, advancements in vaccine research, heightened public understanding of flu prevention, and the early introduction of quadrivalent vaccines in developed regions.

The quadrivalent market is anticipated to experience significant expansion over the coming years. By 2030, its value is projected to reach $15.37 billion, exhibiting a compound annual growth rate (CAGR) of 10.1%. This projected growth is driven by factors such as an increasing need for more comprehensive influenza protection, advancements in vaccine delivery methods, the spread of immunization initiatives in developing regions, greater financial input into biotechnology and precision medicine, alongside supportive reimbursement frameworks and governmental backing. Key developments anticipated during this period encompass enhancing vaccine formulations, broadening immunization programs to cover more age groups, advancements in cold chain logistics and distribution, wider coverage for multiple influenza strains, and strict adherence to regulatory standards and quality control.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9335&type=smp

Which Key Factors Are Driving The Quadrivalent Market Growth?

The global expansion of immunization coverage is anticipated to propel the quadrivalent market. This coverage signifies the proportion of a population that has received specific or recommended vaccines within a defined period. As immunization coverage increases, it drives higher demand for vaccines, particularly quadrivalent vaccines, which offer protection against four strains and are frequently integrated into routine vaccination programs to address multiple disease threats in a single shot. For instance, the World Health Organization, an international public health organization based in Switzerland, reported in July 2025 that the global coverage for the first dose of the HPV vaccine in girls climbed from 27% in 2023 to 31% in 2024. Therefore, growing immunization coverage worldwide will fuel quadrivalent market growth in the future.

How Is The Quadrivalent Market Broken Down By Segment Categories?

The quadrivalent market covered in this report is segmented –

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray

2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies

3) By Disease: Cancer, Hepatitis, Pneumococcal Disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

Subsegments:

1) By Intradermal Shot: Standard Intradermal Injection, Needle-Free Intradermal Delivery

2) By Intramuscular Injection: Standard Intramuscular Injection, Adjuvanted Intramuscular Injection

3) By Nasal Spray: Live Attenuated Nasal Spray, Inactivated Nasal Spray

Which Trends Are Guiding The Direction Of The Quadrivalent Market?

Leading companies in the quadrivalent market are concentrating on safer, innovative vaccine delivery systems, such as nano-particle technology, to increase their revenues. This nano-particle technology mimics the virus’s outer structure using virus-like particles (VLPs) without containing any live genetic material, which boosts both safety and immune response. For example, in March 2024, Cadila Pharmaceuticals, an India-based pharmaceutical company, introduced its advanced Quadrivalent Influenza Vaccine, a sophisticated immunization engineered to offer protection against four distinct strains of the influenza virus, specifically two A strains (H1N1 and H3N2) and two B strains. This quadrivalent formulation improves the vaccine’s effectiveness by targeting a broader array of circulating influenza viruses, making it particularly valuable during flu seasons. The aQIV is designed to stimulate a powerful immune response, thereby reducing the incidence of influenza-related illness and fatalities. Its development highlights continuous endeavors to enhance public health outcomes as viral strains evolve.

Which Players Are Present In The Quadrivalent Market Space?

Major companies operating in the quadrivalent market are AstraZeneca Plc, Serum Institute of India Private Limited, Sanofi S.A., GlaxoSmithKline Plc, CSL Limited, Bharat Biotech International Limited, Hualan Biological Engineering Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Pfizer Inc., Walvax Biotechnology Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Biological E. Limited, GSK Biologicals SA, Institute of Vaccines and Biological Products Chinese Academy of Medical Sciences, Wuhan Institute of Biological Products Co. Ltd., Beijing Tian Tan Biological Products Co. Ltd., Shanghai Zhijiang Bio-pharm Co. Ltd., Bio Farma, Butantan Institute, Pasteur Institute of India, China National Biotec Group Co. Ltd. (CNBG)

Get The Full Quadrivalent Market Report:

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Which Region Represents The Largest Share Of The Quadrivalent Market?

North America was the largest region in the quadrivalent market in 2025. The regions covered in the quadrivalent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Quadrivalent Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Browse Through More Reports Similar to the Global Quadrivalent Market 2026, By The Business Research Company

Quadrivalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Pentavalent Market Report 2026

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795